Biosimilars

Biologics have transformed the treatment of many life-limiting diseases, but with the significant burden of disease, healthcare systems are continuing to face a financial challenge to meet the needs of patients. The utilization of high-quality, lower-cost biosimilars can improve the sustainability of healthcare systems, providing the potential for more patients to benefit from biological medicines. We are dedicated to improving the lives of patients by promoting the use of biosimilars to expand overall treatment options and contribute to the quality and sustainability of the US healthcare system.